Wellorithm review

The two medications most readers come to Wellorithm for, compounded semaglutide and compounded tirzepatide, carry no published price at all. Every one of those product cards ends in a button that goes to a quiz, so the first cost you see arrives after the intake, not before it.

That silence was checked rather than assumed. On 2026-08-28 all 13 routes on the site were loaded and rendered, along with sitemap.xml, robots.txt and all 36 JavaScript files the pages load; /pricing, /plans, /cost, /semaglutide and /tirzepatide all return a not-found page. The four compounded listings, injectable semaglutide, the GLP tablets and the two oral dissolving variants, show a description and a get-started link and nothing else, and each link resolves to the same questionnaire at /quiz-2. The homepage FAQ answers the cost question by describing the category rather than the company: "Pricing varies based on the individual plan and services selected. Many programs offer transparent pricing, including consultations, medications, and ongoing support, often with flexible payment options."

The branded side is a different story, and it is newer than our previous read. Ozempic and Zepbound each list at $1,199 a month, Wegovy at $899, Mounjaro at $1,399, and NAD+ and sermorelin at $150 for the first month and $200 a month after that. Each of those pages also promises a discount applied at checkout, no hidden fees and free expedited shipping. So the company is willing to print a number; it just does not print one for either compounded GLP-1.

Those branded rates are worth converting before anyone treats them as an alternative. A year of Mounjaro at $1,399 a month is $16,788, and Ozempic or Zepbound at $1,199 is $14,388. The pages that carry these figures are also the pages missing from the site's own sitemap.xml, which lists seven URLs, was last updated in April and omits every product page, so search engines are being pointed at less of this site than a visitor can reach.

Two cautions on the numbers it does print. The Ozempic and Zepbound pages contradict themselves: the hero says "$1,119 per month" while the card lower on the same page says "$1,199/month," an $80 gap with no explanation of which one bills. And the NAD+ and sermorelin figures are an introductory rate, $150 for month one and $200 every month after, so the annual cost is $2,350, not $1,800.

Coverage contradicts itself too, on two of its own pages. The homepage FAQ says Wellorithm is available in 49 states and cannot serve Louisiana, while the terms page says the services are available "in all 50 states plus D.C." The 49-state answer is the specific one and is what the summary above reflects, but if you are in Louisiana, get that confirmed in writing before paying anything.

Some of the trust signals do not survive a close read. The four clinicians presented as certified obesity specialists are listed under cardiac surgery, a pediatric clinic, gynecology and cardiac surgery, with none in obesity medicine. "100% Customer Satisfaction" is stated as a fact and is not the kind of claim anyone can substantiate. And the homepage testimonial still shows an unedited instruction to whoever was meant to write it, rendering to visitors as "Gabriela Story - change description to: After losing over 40 pounds in less than four months with GLP-1s, I finally recognize myself again." A page that ships an editing note to the public is a page nobody proofread.

What is genuinely here is format choice: both molecules as oral dissolving tablets as well as injections, four branded pens on the same account, sermorelin alongside the GLP-1 line, and support on a published phone number. If an oral dissolving tablet is what you want and you accept a two-minute intake before learning any cost, that is a real reason to start the quiz. If you are comparing prices tonight, there is nothing here to compare: the four programs that would answer your question are the four with no number on them, and the low transparency and price stability scores above are measuring exactly that.